|1.||Lin, Shih-Hua: 7 articles (09/2015 - 10/2003)|
|2.||Decherchi, Patrick: 4 articles (09/2015 - 11/2007)|
|3.||Burke, David: 3 articles (06/2013 - 11/2008)|
|4.||Shekarabi, Masoud: 3 articles (01/2013 - 09/2008)|
|5.||Laganière, Janet: 3 articles (01/2013 - 09/2008)|
|6.||Salin-Cantegrel, Adèle: 3 articles (01/2013 - 09/2008)|
|7.||Rouleau, Guy A: 3 articles (01/2013 - 09/2008)|
|8.||Lapointe, Jean-Yves: 3 articles (01/2013 - 09/2008)|
|9.||DeVizio, William: 3 articles (01/2009 - 01/2004)|
|10.||Zhang, Yun Po: 3 articles (01/2009 - 01/2004)|
05/01/1994 - "Controlled infusion of a concentrated solution of potassium chloride at a rate of 0.25 mmol/kg/hour is a safe and effective way to achieve rapid correction of hypokalemia with ECG changes, using minimal fluid volumes."
05/01/1994 - "Safety and efficacy of a concentrated potassium chloride solution infusion for rapid correction of hypokalemia."
03/01/2014 - "Efficacy of oral potassium chloride administration in treating lactating dairy cows with experimentally induced hypokalemia, hypochloremia, and alkalemia."
12/01/2012 - "Moderate hypokalemia occurred once in one subject in the MN-221-CL-004 study and twice in one subject in the MN-221-CL-005 study and were transient and returned to normal range following single oral potassium chloride treatments. "
09/01/2015 - "Exclusion of TPP can be accomplished by immediate evaluation of urinary K+ excretion, acid-base status, and the amount of potassium chloride required to correct hypokalemia at presentation."
01/01/2015 - "The synthesis and characterization of a novel potassium chloride-fluoridated hydroxyapatite varnish for treating dentin hypersensitivity."
02/01/1994 - "Sensodyne F is a potassium chloride (KCl) and sodium monofluorphosphate (MFP) containing dentifrice currently marketed in the United Kingdom and Germany was compared to a KCl only dentifrice and to a placebo dentifrice for effectiveness in alleviating dentin hypersensitivity. "
08/01/1996 - "Previous studies have demonstrated efficacy of desensitizing dentifrices containing strontium acetate/sodium fluoride (SrAc2F) and potassium chloride/sodium monofluorophosphate (KCl/MFP) in alleviating discomfort arising from cervical dentine sensitivity (CDS). "
11/01/2001 - "These studies demonstrate that the new dentifrice, containing potassium nitrate, stannous fluoride and sodium fluoride is significantly better at reducing dentine hypersensitivity than both the dentifrice containing sodium fluoride and the one containing potassium chloride, triclosan and sodium fluoride (Sensodyne F)."
01/01/2009 - "This paper presents the results of one of two eight-week dentin hypersensitivity clinical studies in which the efficacy of a novel toothpaste containing 8.0% arginine, calcium carbonate, and 1450 ppm fluoride as sodium monofluorophosphate (MFP) was compared to that of a benchmark commercial toothpaste containing 2% potassium ion, dosed as 3.75% potassium chloride, and 1450 ppm fluoride as sodium fluoride (NaF). "
|3.||Hypertension (High Blood Pressure)
05/01/1987 - "Double-blind, placebo-controlled trial of potassium chloride in the treatment of mild hypertension."
06/01/1984 - "Eight controlled 1- or 2-wk experiments involving 225 healthy male subjects and one study of 18 patients with hypertension, nine of whom were long-term users of a wax-matrix potassium chloride preparation, were conducted to evaluate the upper gastrointestinal safety of oral KCl supplements. "
07/01/1967 - "[A study of various indices of the functional state of the adrenal cortex and mineral metabolism in patients with hypertension during potassium chloride loading]."
04/01/2010 - "Nutritional interventions, like potassium chloride (KCl) diet supplementation, and exercises are common nonpharmacological indications for treating hypertension. "
02/01/1992 - "Potassium chloride lowers blood pressure and causes natriuresis in older patients with hypertension."
09/01/2007 - "By implementing the recommendations in the literature regarding the use of potassium chloride solutions, the possible hazards of hyperkalemia associated with intravenous use were eliminated, thus taking a proactive approach to medication safety at HaEmek Medical Center."
11/01/1985 - "After reviewing the available data on drug-induced hyperkalemia, we conclude that the situation has not improved since Lawson quantitatively documented the substantial risks of potassium chloride over a decade ago (90). "
05/01/2014 - "One patient developed hyperkalemia after a total potassium chloride supplementation of 110 mmol. "
01/01/2009 - "Approximately, 174 mmol of potassium chloride was administrated to restore his muscle strength within 12 hours, but rebound hyperkalemia (6.1 mmol/L) developed upon recovery. "
09/01/2007 - "Potassium chloride (0.08 mEq/kg/min) was infused for periods of less than 30 min to induce electrocardiographic (EKG) changes characteristic of hyperkalemia. "
12/01/1999 - "In addition, in the FA the maximum responses to both noradrenaline (control 3.64 +/- 0.31 KPa, (N = 8); failure 5.11 +/- 0.35 KPa, (N = 7) P = 0.004) and potassium chloride (control 2.18 +/- 0.26 KPa, (N = 8); failure 4.46 +/- 0.25 KPa, (N = 7) P = 0.001) were significantly increased in heart failure. "
11/15/1996 - "Endogenous sodium-potassium-chloride cotransport inhibitor in congestive heart failure."
01/01/1995 - "[Effects of potassium chloride and triamterene on kaliuresis, natriuresis and diuresis in congestive heart failure]."
02/01/1993 - "Arteries from six patients with congestive heart failure contracted to only 65% of the maximum response recorded in nine arteries from normal volunteers when activated by potassium chloride (124 mM), noradrenaline (1 microM), or both. "
12/01/1987 - "A case study is presented in which a 70-year-old woman who went into cardiac failure following unsuccessful surgery was injected with potassium chloride by her concerned physician after morphine had no effect. "
|2.||Sodium Fluoride (Ossin)
|3.||fluorophosphate (sodium monofluorophosphate)
|8.||Calcium Carbonate (Limestone)
|10.||Acetylcholine (Acetylcholine Chloride)
|3.||Fluid Therapy (Oral Rehydration Therapy)
|5.||Induced Heart Arrest (Cardioplegia)